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Margaret Buckingham was presented as a newly elected member to the National Academy of Sciences on 28 April
2012. Over the course of her career, Dr Buckingham made many seminal contributions to the understanding of
skeletal muscle and cardiac development. Her studies on cardiac progenitor populations has provided insight into
understanding heart malformations, while her work on skeletal muscle progenitors has elucidated their embryonic
origins and the transcriptional hierarchies controlling their developmental progression.
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Dr Margaret Buckingham, a much-respected investigator
who has made many significant contributions to our
understanding of skeletal muscle and cardiac develop-
ment, was elected to the National Academy of Sciences in
2011 and presented on 28 April, 2012. Dr Buckingham is
Professor in the Department of Developmental Biology at
the Pasteur Institute in Paris. She has been awarded many
prestigious distinctions including that of Officier de la Lé-
gion d’Honneur and Officier de l'Ordre National du Mér-
ite, to name but two.
Dr Buckingham’s early studies involved the cloning and
characterization of actin and myosin genes from cardiac
and skeletal muscle [1-4]. She has made seminal contribu-
tions to our understanding of cardiac development. She
identified the second heart field [5] and showed its im-
portant contribution to the poles of the heart. These car-
diac progenitors are regulated by a distinct genetic
network and in this context, Dr Buckingham has worked
on the role of fibroblast growth factor (FGF) signaling in
the formation of the outflow tract and pharyngeal arteries
[6]. Her studies of cardiac development revealed that that
two cell lineages contribute to the myocardium [7].
Lineage studies also demonstrated a clonal relationship
between arterial pole myocardium and head muscles [8].Correspondence: mrudnicki@ohri.ca
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importance in understanding heart malformations.
Dr Buckingham has also made major contributions to
the molecular genetic analysis of skeletal muscle devel-
opment. She was the first to analyze expression of the
myogenic regulatory factors of the MyoD family during
mouse embryogenesis [9] and the behavior of cells in the
absence of Myf5 [10].
Her more recent work demonstrated that skeletal
muscle growth depends on a somite-derived population of
progenitor cells that express Pax3 and Pax7 [11]. She
established that the Myf5 gene is activated by Pax3
through specific regulatory elements [12], and that Pax3
regulation of FGF signaling affects the balance between
progenitor self-renewal and differentiation [13]. She
showed genetically that before cells acquire myogenic po-
tential, the equilibrium between Pax3 and Foxc2 expres-
sion in the somite regulates the choice between myogenic
versus vascular cell fate [14]. After demonstrating the key
role of satellite cells in adult muscle regeneration [15], she
investigated satellite-cell quiescence, showing recently that
microRNA31 targets Myf5 mRNA, and that both are
sequestered in micro-ribonucleoprotein granules which
breakdown on satellite cell activation [16]. She also identi-
fied microRNA-27 as a regulator of Pax3 production [17].
Dr Buckingham’s election to the academy recognizes
her many significant contributions as a leading scholar in
the molecular genetic study of striated muscle formation.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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